Abstract: The invention provides an improved method for the purification of nucleic acid molecules, which method comprises generating a cellular lysate containing the nucleic acid; contacting the lysate with an anion exchanger bound to a solid support matrix under conditions such that the anion exchanger binds the nucleic acid; followed by eluting the nucleic acid from the anion exchanger with an aqueous mobile phase comprising an elution solution; and desalting the eluted nucleic acid such that it is suitable for downstream applications. The improvement of the method includes providing the anion exchanger in a packed column, wherein the column is packed using a salt solution containing an antimicrobial agent. In addition, the salt solution has a salt concentration similar to that of the lysate, such that the column does not need equilibration prior to sample loading.
Abstract: Disclosed is a process for separating and/or purifying a nucleic acid by elution of the nucleic acid from anion exchange resins under conditions of high salt concentration and the presence in the eluant of an additive comprising guanidine, or a guanidine-like derivative. The process allows high recovery of nucleic acids from anion exchange resins without impairing the nucleic acid stability as compared with conventional ion exchange chromatographic procedures.
Abstract: The invention provides an improved method for the purification of nucleic acid molecules, which method comprises generating a cellular lysate containing the nucleic acid; contacting the lysate with an anion exchanger bound to a solid support matrix under conditions such that the anion exchanger binds the nucleic acid; followed by eluting the nucleic acid from the anion exchanger with an aqueous mobile phase comprising an elution solution; and desalting the eluted nucleic acid such that it is suitable for downstream applications. The improvement of the method includes adding in the elution solution a composition such that the pH of the aqueous mobile phase is between about pH 9 and about pH 13, wherein the presence of the composition in the elution solution provides an increase in nucleic acid recovery, as compared with the recovery in the absence of the composition.
Abstract: The present invention discloses a high-density parallel channel design for a microfabricated capillary array electrophoresis chip, with vertical T or double T design for sample injection. An alternative embodiment of the invention includes a closed buffer reservoirs with integrated electrodes and buffer feeding ports. Also disclosed are novel sample loading and injection methods, including the use of using either a capillary array connected to an electrode, or an array of metal pens as the loader/electrode.
Type:
Grant
Filed:
September 25, 2003
Date of Patent:
January 26, 2010
Assignee:
GE Healthcare (SV) Corp.
Inventors:
Iuliu-Ioan Blaga, Jing Ni, William D. Nielsen
Abstract: The present invention relates to an IgG-binding compound, which more specifically has affinity for human IgGs of ?-type and functional derivatives thereof. More specifically, the compound according to the invention comprises an N,N-alkylated urea moiety located between an aromatic part and another part, which is a linear or cyclic substituted or unsubstituted aliphatic group. The compound binds to a pocket-shaped binding site present on all human IgG ?-Fabs, which site is located between the two domains (CH1 and CL) of its constant part. Accordingly, the compound according to the invention is a ligand for human IgGs of ?-type, and consequently, the invention also relates to a separation matrix for affinity chromatography, which matrix comprises said compound, as well as to other uses of the compound.
Type:
Grant
Filed:
September 12, 2003
Date of Patent:
January 12, 2010
Assignee:
GE Healthcare Bio-Sciences AB
Inventors:
Andreas Axén, Herbert Baumann, Enrique Carredano, Anna Grönberg, Elles Steensma
Abstract: The invention relates to a method of characterizing interaction between two species in a liquid environment, wherein a liquid comprising said at least one species is passed as a flow through a measurement system, and wherein the interaction takes place within said measurement system. The method comprises generating a concentration gradient of at least a first one of said species or of at least one other species having an influence on the interaction or on interacted components. The flow of liquid is passed through a sensor device, and a result of interaction between said at least two species is detected. The flow of liquid is intersected at least once with a further liquid before the flow is passed through said sensor, so as to create at least two separated liquid segments having different concentrations of at least one of said species forming the concentration gradient.
Abstract: The present invention relates to a chromatographic adsorbent for selectively adsorbing IgG, comprising the following formula and its corresponding enol-form, wherein X represents O, S, or NH; R1 represents H, C1-6 alkyl, C1-6 alkoxy, C1-6 alkoxy-C1-6 alkyl, Ar, —C(O)NHR3, —C(O)—R3 or halo; R2 represents H, C1-3 alkyl or halo; R3 represents H, C1-6 alkyl, C1-6 alkoxy, C1-6 alkoxy-C1-6 alkyl or Ar; n represents 0, 1, 2 or 3; Y represents a carrier. The present invention also relates to a method of producing said adsorbent as well as use thereof for separating substances by affinity chromatography.
Type:
Grant
Filed:
June 17, 2009
Date of Patent:
December 1, 2009
Assignee:
GE Healthcare Bio-Sciences AB
Inventors:
Mathias Alterman, Andreas Axen, Enrique Carredano, Anna Gronberg, Jinyu Zou
Abstract: The present invention relates to polypeptide and nucleic acids constructs which are useful for determining the cell cycle status of a mammalian cell. Host cells transfected with these nucleic acid constructs can be used to determine the effects that test agents have upon the mammalian cell cycle.
Type:
Grant
Filed:
July 22, 2005
Date of Patent:
November 3, 2009
Assignees:
GE Healthcare UK Limited, Vanderbilt University
Inventors:
Suzanne Hancock, Simon Stubbs, Nicholas Thomas, Ellen Fanning, Jinming Gu
Abstract: The present invention relates to method of manufacturing a sulphonate-functionalized (S-functionalized) cation exchanger, which method comprises reacting olefinic groups with bisulphite in the presence of at least one amine oxide, such as N-methyl morpholine oxide (NMO). The olefinic groups of the carrier may be allyl groups; which may be provided on extenders such as polyhydroxyfunctional polymers. In one embodiment, the carrier is made of agarose with improved flow pressure properties.
Type:
Grant
Filed:
November 16, 2006
Date of Patent:
October 27, 2009
Assignee:
GE Healthcare Bio-Sciences AB
Inventors:
Andreas Axen, Gunnar Glad, Henrik Ihre, Anders Larsson, Nils Norrman
Abstract: Methods and devices are provided for controlling a fluid flow over a sensing surface within a flow cell. The methods employ laminar flow techniques to position a fluid flow over one or more discrete sensing areas on the sensing surface of the flow cell. Such methods permit selective sensitization of the discrete sensing areas, and provide selective contact of the discrete sensing areas with a sample fluid flow. Immobilization of a ligand upon the discrete sensing area, followed by selective contact with an analyte contained within the sample fluid flow, allows analysis by a wide variety of techniques. Sensitized sensing surfaces, and sensor devices and systems are also provided.
Type:
Grant
Filed:
December 6, 2005
Date of Patent:
September 1, 2009
Assignee:
GE Healthcare Bio-Sciences AB
Inventors:
Magnus Malmqvist, Håkan Roos, Stefan Sjölander, Mattias Tidare, Håkan Sjödin, Ralph Stålberg